← Back to Clinical Trials
RecruitingNCT07369258

Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionCritical Illness
SponsorHOSPITAL BRITANICO DE BUENOS AIRES
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment330
SexALL
Min Age65 Years
Max AgeN/A
Start Date2026-02-02
Completion2026-10-31
Interventions
Personalized MusicRelaxing MusicStandard of Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if listening to music can prevent delirium in older adults admitted to the Intensive Care Unit (ICU). The main questions it aims to answer are: * Does listening to music increase the number of days participants are alive and free of delirium and coma during a 7-day period? * Is personalized music more effective than generic relaxing music? Researchers will compare Personalized Music and Relaxing Music to Standard Care (no study-provided music) to see if the music intervention improves delirium outcomes compared to usual care. Participants will: * Listen to music through headphones twice daily (morning and afternoon) for at least 30 minutes during a 7-day period (intervention groups). * Receive standard ICU care and undergo daily assessments for delirium and level of consciousness.

Eligibility Criteria

Inclusion Criteria: * Age 65 years or older. * Negative Confusion Assessment Method for the ICU (CAM-ICU) at the time of randomization. * Expected ICU length of stay of at least 48 hours based on clinical judgement at admission (e.g., need for mechanical ventilation, vasopressors, invasive monitoring). Exclusion Criteria: * Positive CAM-ICU prior to randomization. * Acute primary Central Nervous System pathology (e.g., ischemic or hemorrhagic stroke, traumatic brain injury, meningoencephalitis, intracranial hypertension) presenting with altered sensorium (Glasgow Coma Scale at admission \< 14) or focal deficit preventing cognitive assessment (e.g., severe aphasia). * Severe chronic cognitive impairment or advanced dementia, defined by a known history of severe functional dependence prior to admission (requiring permanent assistance for basic activities of daily living such as feeding or grooming) * Unresolved auditory or visual impairment. * Suspected or confirmed intoxication with dru

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology